BusinessCURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis IndustryBy Nasdaq OMXMay 10, 2017, 1:01 PM UTC
BusinessCURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis IndustryBy Nasdaq OMXMay 10, 2017, 1:01 PM UTC
BusinessCURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate DevelopmentBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessCURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate DevelopmentBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessCURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate DevelopmentBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessMaricann Secures $42,500,000 Non-Dilutive Financing for Further German ExpansionBy Nasdaq OMXMay 4, 2017, 3:24 PM UTC
BusinessCURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of DirectorsBy Nasdaq OMXMay 3, 2017, 1:01 PM UTC
BusinessEarth Science Tech, Inc. Shares Achievements & Updates on it’s Cannabis CBD-Based Nutraceutical Patent CompoundingBy Nasdaq OMXMay 2, 2017, 11:45 AM UTC
